Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 2
1990 1
1993 2
1994 1
1996 1
1997 1
1998 3
1999 1
2001 2
2002 2
2004 1
2005 1
2008 5
2010 1
2015 1
2016 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
[Lactic acidosis following antiretroviral therapy].
Moreno-Cuerda VJ, Rubio García R. Moreno-Cuerda VJ, et al. Among authors: rubio garcia r. Med Clin (Barc). 2005 Jul 9;125(6):213-4. doi: 10.1157/13077381. Med Clin (Barc). 2005. PMID: 16022834 Spanish. No abstract available.
[Vasculitis associated with HIV infection].
Fernández-Miranda Parra C, Rubio García R, Pulido Ortega F. Fernández-Miranda Parra C, et al. Among authors: rubio garcia r. Rev Clin Esp. 1996 Oct;196(10):714-20. Rev Clin Esp. 1996. PMID: 9005477 Review. Spanish. No abstract available.
Misindentification of Mycobacterium kumamotonense as M. tuberculosis.
Rodríguez-Aranda A, Jimenez MS, Yubero J, Chaves F, Rubio-Garcia R, Palenque E, García MJ, Menendez MC. Rodríguez-Aranda A, et al. Among authors: rubio garcia r. Emerg Infect Dis. 2010 Jul;16(7):1178-80. doi: 10.3201/eid1607.091913. Emerg Infect Dis. 2010. PMID: 20587204 Free PMC article. No abstract available.
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
Mantsios A, Murray M, Karver TS, Davis W, Margolis D, Kumar P, Swindells S, Bredeek UF, García Del Toro M, Garcia Gasalla M, Rubio García R, Antela A, Hudson K, Griffith S, Kerrigan D. Mantsios A, et al. Among authors: rubio garcia r. AIDS Behav. 2020 Dec;24(12):3473-3481. doi: 10.1007/s10461-020-02918-x. AIDS Behav. 2020. PMID: 32410051 Clinical Trial.
Maraviroc for previously treated patients with R5 HIV-1 infection.
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Gulick RM, et al. N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152. N Engl J Med. 2008. PMID: 18832244 Free PMC article. Clinical Trial.
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams. Fätkenheuer G, et al. N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154. N Engl J Med. 2008. PMID: 18832245 Free article.
Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort.
Torrecilla García E, Yebra Sanz G, Llácer-Delicado T, Rubio García R, González-García J, García García F, López-Aldeguer J, Asensi Álvarez V, Holguín Fernández Á; Cohort of the Spanish AIDS Research Network (CoRIS). Torrecilla García E, et al. Among authors: rubio garcia r. Enferm Infecc Microbiol Clin. 2016 Jun-Jul;34(6):353-60. doi: 10.1016/j.eimc.2015.07.016. Epub 2015 Sep 11. Enferm Infecc Microbiol Clin. 2016. PMID: 26364856
28 results